287 related articles for article (PubMed ID: 19729614)
1. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk.
Musunuru K; Orho-Melander M; Caulfield MP; Li S; Salameh WA; Reitz RE; Berglund G; Hedblad B; Engström G; Williams PT; Kathiresan S; Melander O; Krauss RM
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1975-80. PubMed ID: 19729614
[TBL] [Abstract][Full Text] [Related]
2. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
[TBL] [Abstract][Full Text] [Related]
3. Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography.
Hirowatari Y; Tsunoda Y; Ogura Y; Homma Y
Atherosclerosis; 2009 Jun; 204(2):e52-7. PubMed ID: 19091316
[TBL] [Abstract][Full Text] [Related]
4. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
Cui Y; Blumenthal RS; Flaws JA; Whiteman MK; Langenberg P; Bachorik PS; Bush TL
Arch Intern Med; 2001 Jun; 161(11):1413-9. PubMed ID: 11386890
[TBL] [Abstract][Full Text] [Related]
5. Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial.
Toth PP; Jones SR; Slee A; Fleg J; Marcovina SM; Lacy M; McBride R; Boden WE
J Clin Lipidol; 2018; 12(3):741-747.e11. PubMed ID: 29627296
[TBL] [Abstract][Full Text] [Related]
6. High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease.
Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shibata T
J Atheroscler Thromb; 2016; 23(1):81-94. PubMed ID: 26289085
[TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
8. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
Mora S; Buring JE; Ridker PM; Cui Y
Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
[TBL] [Abstract][Full Text] [Related]
9. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
11. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
[TBL] [Abstract][Full Text] [Related]
12. Relationship of pericardial fat with lipoprotein distribution: The Multi-Ethnic study of atherosclerosis.
Ong KL; Ding J; McClelland RL; Cheung BM; Criqui MH; Barter PJ; Rye KA; Allison MA
Atherosclerosis; 2015 Aug; 241(2):664-70. PubMed ID: 26117404
[TBL] [Abstract][Full Text] [Related]
13. Influence of fitness status on very-low-density lipoprotein subfractions and lipoprotein(a) in men and women.
Thomas TR; Ziogas G; Harris WS
Metabolism; 1997 Oct; 46(10):1178-83. PubMed ID: 9322803
[TBL] [Abstract][Full Text] [Related]
14. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
15. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
[TBL] [Abstract][Full Text] [Related]
16. LDL subfractions are associated with incident cardiovascular disease in the Malmö Prevention Project Study.
Shiffman D; Louie JZ; Caulfield MP; Nilsson PM; Devlin JJ; Melander O
Atherosclerosis; 2017 Aug; 263():287-292. PubMed ID: 28728064
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
[TBL] [Abstract][Full Text] [Related]
18. Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease.
Zhu CG; Zhang Y; Xu RX; Li S; Wu NQ; Guo YL; Sun J; Li JJ
J Clin Lipidol; 2015; 9(6):794-800. PubMed ID: 26687700
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipoprotein levels as predictors of cardiovascular death in women.
Bass KM; Newschaffer CJ; Klag MJ; Bush TL
Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
[TBL] [Abstract][Full Text] [Related]
20. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
